Abiopharma

ARS Pharmaceuticals Receives FDA Approval to Remove Age Requirement From neffy® 1 mg (epinephrine nasal spray) Label

Kyivstar Delivered 4G Coverage to 630 Communities in 2025

PRF Technologies Provides Year-End 2025 Business Update Highlighting Strategic Progress Across Healthcare and AI-Driven Solar Platforms

Press Release: Sanofi’s Sarclisa subcutaneous formulation administered via on-body injector recommended for EU approval by the CHMP to treat multiple myeloma

Sensus Healthcare Files Lawsuit Against SkinCure Oncology for Breach of Contract

Organon Debuts New Analysis of VTAMA® (tapinarof) cream, 1%, Phase 3 Pooled Data Demonstrating Early and Consistent Skin Clearance and Itch Improvement in Atopic Dermatitis Patients Down to 2 Years of Age

Communiqué de presse : La formulation sous-cutanée de Sarclisa de Sanofi, administrée via un injecteur portable, est recommandée par le CHMP pour approbation dans lUE dans le traitement du myélome multiple

Swedish Defence Materiel Administration (FMV) Places Follow-On Order for Additional Teledyne GAVIA AUV Systems

VisionWave Announces Completion of Internal Research Paper on Conceptual RF-Based Subsurface Sensing Architectures in Connection with Recent Liberia LOE Engagement

Intercontinental Exchange Announces New $600 Million Investment in Polymarket